GRAIL, Inc. (GRAL) vs RadNet, Inc. (RDNT)

GRAIL, Inc. and RadNet, Inc. are both Diagnostics & Research companies. GRAIL, Inc. and RadNet, Inc. are of similar size ($6.1B and $5.5B). GRAIL, Inc. grew revenue faster over the last twelve months: 23.1% against 18.9%. RadNet, Inc. has the higher net margin (−0.93% vs −237.0%) and the higher return on invested capital (2.24% vs −20.8%). Across the 17 metrics below, RadNet, Inc. leads on 12 and GRAIL, Inc. on 5.

Valuation

Metric GRAL RDNT Diagnostics & Research median
P/E n/m n/m 35.56
P/S 30.73 2.35 4.37
P/B 2.00 3.82 3.06
Price to free cash flow n/m 164.99 35.76
EV/EBITDA n/m 19.29 24.35
EV/Sales 25.52 2.62 5.51
Earnings yield (8.28%) (0.39%) (1.89%)
Free cash flow yield (5.83%) 0.61% (0.15%)

Profitability

Metric GRAL RDNT Diagnostics & Research median
Gross margin (31.31%) 11.53% 50.89%
Operating margin (338.40%) 3.12% (8.57%)
Net margin (236.95%) (0.93%) (6.37%)
Free cash flow margin (179.21%) 3.28% 0.00%
Return on equity (16.12%) (1.64%) (2.92%)
Return on assets (14.12%) (0.55%) (6.71%)
Return on invested capital (20.79%) 2.24% 0.00%

Growth

Metric GRAL RDNT Diagnostics & Research median
Revenue growth (TTM) 23.07% 18.92% 7.69%
EPS growth (last fiscal year) 82.51% (725.00%) 25.92%
Revenue growth, 5-year CAGR — 13.74% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GRAL RDNT Diagnostics & Research median
Debt to equity 0.00 0.94 0.11
Current ratio 10.95 1.48 2.02
Net debt to EBITDA 2.27 1.16 0.70

Dividend

Metric GRAL RDNT Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric GRAL RDNT Diagnostics & Research median
Market cap 6.05b 5.54b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack